Abnova Taiwan Corp (4133) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.010x

Based on the latest financial reports, Abnova Taiwan Corp (4133) has a cash flow conversion efficiency ratio of 0.010x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$12.73 Million ≈ $400.97K USD) by net assets (NT$1.26 Billion ≈ $39.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Abnova Taiwan Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Abnova Taiwan Corp - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Abnova Taiwan Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Abnova Taiwan Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Abnova Taiwan Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Matahari Putra Prima Tbk
JK:MPPA
0.112x
BJC Heavy Industries Public Company Limited
BK:BJCHI
0.054x
BG Staffing Inc
NYSE:BGSF
0.042x
Insung Information Co. Ltd
KQ:033230
-0.098x
FOODWELL Co. Ltd
KQ:005670
0.092x
Globetronics Tech Bhd
KLSE:7022
-0.016x
ALANDEQGRP FPO
AU:AEG
-1.327x
Phunware Inc
NASDAQ:PHUN
-0.029x

Annual Cash Flow Conversion Efficiency for Abnova Taiwan Corp (2009–2025)

The table below shows the annual cash flow conversion efficiency of Abnova Taiwan Corp from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Abnova Taiwan Corp (4133) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$1.26 Billion
≈ $39.59 Million
NT$-4.19 Million
≈ $-132.07K
-0.003x -108.59%
2024-12-31 NT$1.31 Billion
≈ $41.25 Million
NT$50.85 Million
≈ $1.60 Million
0.039x -34.46%
2023-12-31 NT$1.29 Billion
≈ $40.53 Million
NT$76.22 Million
≈ $2.40 Million
0.059x -42.17%
2022-12-31 NT$1.29 Billion
≈ $40.70 Million
NT$132.37 Million
≈ $4.17 Million
0.102x +33.67%
2021-12-31 NT$1.21 Billion
≈ $38.18 Million
NT$92.88 Million
≈ $2.93 Million
0.077x -11.85%
2020-12-31 NT$1.21 Billion
≈ $38.16 Million
NT$105.30 Million
≈ $3.32 Million
0.087x +39.14%
2019-12-31 NT$1.19 Billion
≈ $37.57 Million
NT$74.51 Million
≈ $2.35 Million
0.062x -13.99%
2018-12-31 NT$1.23 Billion
≈ $38.66 Million
NT$89.17 Million
≈ $2.81 Million
0.073x +31.77%
2017-12-31 NT$1.22 Billion
≈ $38.59 Million
NT$67.53 Million
≈ $2.13 Million
0.055x -9.84%
2016-12-31 NT$1.18 Billion
≈ $37.06 Million
NT$71.94 Million
≈ $2.27 Million
0.061x -2.83%
2015-12-31 NT$1.17 Billion
≈ $36.76 Million
NT$73.43 Million
≈ $2.31 Million
0.063x -17.82%
2014-12-31 NT$1.23 Billion
≈ $38.74 Million
NT$94.18 Million
≈ $2.97 Million
0.077x -14.21%
2013-12-31 NT$1.23 Billion
≈ $38.74 Million
NT$109.78 Million
≈ $3.46 Million
0.089x +44.31%
2012-12-31 NT$1.23 Billion
≈ $38.72 Million
NT$76.02 Million
≈ $2.40 Million
0.062x -41.44%
2011-12-31 NT$1.27 Billion
≈ $40.03 Million
NT$134.22 Million
≈ $4.23 Million
0.106x +17.26%
2010-12-31 NT$1.27 Billion
≈ $40.01 Million
NT$114.40 Million
≈ $3.60 Million
0.090x +71.09%
2009-12-31 NT$1.21 Billion
≈ $38.13 Million
NT$63.72 Million
≈ $2.01 Million
0.053x --

About Abnova Taiwan Corp

TW:4133 Taiwan Biotechnology
Market Cap
$39.49 Million
NT$1.25 Billion TWD
Market Cap Rank
#22763 Global
#1430 in Taiwan
Share Price
NT$20.70
Change (1 day)
+0.00%
52-Week Range
NT$20.55 - NT$29.00
All Time High
NT$149.53
About

Abnova (Taiwan) Corporation engages in the research, development, manufacturing, and sales of monoclonal and multiclonal antibodies, proteins, medical diagnostic instruments, and testing reagents. The company's products portfolio includes SARS-CoV/CoV-2, DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems,… Read more